Ownership history in Foundry Partners, LLC · 12 quarters on record
This page tracks every 13F SEC filing in which Foundry Partners, LLC reported a position in AVANOS MEDICAL (AVNS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | REDUCED | 119,870 | -43,160 | -26.5% | 0.10% | $1.9M | $15.92 |
| 2024 Q3 | ADDED | 163,030 | +1,800 | +1.1% | 0.19% | $3.9M | $24.03 |
| 2024 Q2 | REDUCED | 161,230 | -2,025 | -1.2% | 0.17% | $3.2M | $19.92 |
| 2024 Q1 | REDUCED | 163,255 | -207,774 | -56.0% | 0.17% | $3.3M | $19.91 |
| 2023 Q4 | ADDED | 371,029 | +158,473 | +74.6% | 0.50% | $8.3M | $22.43 |
| 2023 Q3 | ADDED | 212,556 | +39,068 | +22.5% | 0.27% | $4.3M | $20.22 |
| 2023 Q2 | ADDED | 173,488 | +43,868 | +33.8% | 0.27% | $4.4M | $25.56 |
| 2023 Q1 | ADDED | 129,620 | +120,200 | +1276.0% | 0.24% | $3.9M | $29.74 |
| 2022 Q4 | REDUCED | 9,420 | -220 | -2.3% | 0.01% | $255K | $27.06 |
| 2022 Q3 | REDUCED | 9,640 | -185 | -1.9% | 0.01% | $210K | $21.78 |
As of 2025 Q4 — sorted by position size